Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 639

1.

Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.

Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R.

AJNR Am J Neuroradiol. 1995 Jan;16(1):141-7. Erratum in: AJNR Am J Neuroradiol 1995 Apr;16(4):808.

2.

Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK.

AJNR Am J Neuroradiol. 1995 Sep;16(8):1593-603.

3.

Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1.

Alkan A, Sarac K, Kutlu R, Yakinci C, Sigirci A, Aslan M, Ozcan H, Yologlu S.

Magn Reson Imaging. 2003 Nov;21(9):1049-53.

PMID:
14684211
4.

Proton magnetic resonance spectroscopy of brain in congenital myotonic dystrophy.

Hashimoto T, Tayama M, Yoshimoto T, Miyazaki M, Harada M, Miyoshi H, Tanouchi M, Kuroda Y.

Pediatr Neurol. 1995 May;12(4):335-40.

PMID:
7546006
5.

Short TE proton MRS and neurofibromatosis type 1 intracranial lesions.

Norfray JF, Darling C, Byrd S, Ross BD, Schwalm C, Miller R, Tomita T.

J Comput Assist Tomogr. 1999 Nov-Dec;23(6):994-1003.

PMID:
10589584
6.

Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.

Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D, Kun LE, Taylor J.

Neurosurgery. 1997 Feb;40(2):331-7; discussion 337-8. Review.

PMID:
9007866
7.
8.

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.

9.
10.

Proton MR spectroscopy in patients with seizure disorders.

Breiter SN, Arroyo S, Mathews VP, Lesser RP, Bryan RN, Barker PB.

AJNR Am J Neuroradiol. 1994 Feb;15(2):373-84.

PMID:
8192088
11.

Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1.

Gonen O, Wang ZJ, Viswanathan AK, Molloy PT, Zimmerman RA.

AJNR Am J Neuroradiol. 1999 Aug;20(7):1333-41.

12.

Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.

Tong ZY, Toshiaki Y, Wang YJ.

Chin Med J (Engl). 2005 Aug 5;118(15):1251-7.

PMID:
16117877
13.

Proton MR spectroscopy of tumefactive demyelinating lesions.

Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2002 Sep;23(8):1378-86.

14.

Proton MR spectroscopy of childhood adrenoleukodystrophy.

Rajanayagam V, Grad J, Krivit W, Loes DJ, Lockman L, Shapiro E, Balthazor M, Aeppli D, Stillman AE.

AJNR Am J Neuroradiol. 1996 Jun-Jul;17(6):1013-24.

15.

[MR spectroscopy in the differential diagnosis of focal brain lesions in neurofibromatosis type 1 patients].

Alkan A, Kutlu R, Siğirci A, Baysal T, Altinok T, Dusak A, Saraç K.

Tani Girisim Radyol. 2003 Jun;9(2):166-70. Turkish.

16.

Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.

Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T.

AJNR Am J Neuroradiol. 1996 Apr;17(4):737-47.

17.

Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T.

AJNR Am J Neuroradiol. 2003 Feb;24(2):225-33.

18.

Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy.

Thompson JE, Castillo M, Kwock L, Walters B, Beach R.

AJR Am J Roentgenol. 1998 Mar;170(3):771-6.

PMID:
9490972
19.

Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.

Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31.

PMID:
15850898
20.

Supplemental Content

Support Center